| Trial ID: | L4216 |
| Source ID: | NCT00948324
|
| Associated Drug: |
Csii,Ala,Met,Rsg
|
| Title: |
Effect of Intensive Therapy Associated With CSII on β-cell Function With Newly Diagnosed Type 2 Diabetes
|
| Acronym: |
|
| Status: |
SUSPENDED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: CSII,ALA,MET,RSG
|
| Outcome Measures: |
Primary: beta cell function;fast blood glucose;, 2011/05 |
|
| Sponsor/Collaborators: |
Sponsor: Sun Yat-sen University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
400
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-06
|
| Completion Date: |
2021-12
|
| Results First Posted: |
|
| Last Update Posted: |
2017-10-03
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00948324
|
